BioDatomics has launched a new commercial product for the next-generation sequence data analysis market — a software package called BioDT that the company claims is faster and much simpler to use than existing source software packages.

The Bethesda, Md.-based bioinformatics software developer launched BioDT last week during the American Society of Human Genetics meeting in Boston. It is based on technology that was first developed by BioDatomics CEO and founder Maxim Mikheev and colleagues at the Russian Academy of Sciences between 2002 and 2006.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.